Skip to main content
. 2012 Feb 15;2012(2):CD009665. doi: 10.1002/14651858.CD009665

Comparison 3. Subcutaneous sumatriptan 8 mg versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain‐free at 1 h 2 307 Risk Ratio (M‐H, Fixed, 95% CI) 7.19 [3.86, 13.41]
2 Headache relief at 1 h 3 361 Risk Ratio (M‐H, Fixed, 95% CI) 3.58 [2.71, 4.72]